Researchers from UCL have found that cycling is safer than driving for young males, with 17 to 20 year old drivers facing almost five times greater risk per hour than cyclists of the same age.
The researchers looked at hospital admissions and deaths in England between 2007 and 2009 for pedestrians, cyclists, and drivers. These were studied by age-group and sex. The research is published in the journal PLOS ONE.
Using National Travel Survey data in England for the same time period, the team converted the distance travelled by each age-group, sex and mode of transport into time spent travelling using mean trip speeds.
"What we found is that risks were similar for men aged between 21 and 49 for all three modes of transport and for female pedestrians and drivers aged 21 and 69 years," said lead author Dr Jennifer Mindell (UCL Epidemiology & Public Health). "However, we found that for young male cyclists between 17 and 20 years of age, cycling was markedly safer than travelling by car.
"Perceived road danger is a strong disincentive to cycling and many potential cyclists do not ride on the road due to safety concerns," continued Dr Mindell. "But research regarding the safety of cycling tends to be distorted by a number of errors which are found repeatedly in published papers and policy documents, with many substantially overstating cycling injuries and under-reporting pedestrian injuries."
Those most at risk when travelling were men aged between 17 and 20 for driving, males aged over 70 for cycling and females aged over 70 for walking. In general, fatality rates were substantially higher among males than females.
The team went on to compare the UK data with figures from the Netherlands – a country widely perceived to be bike-friendly. They found a similar pattern in both countries, with teenage male cyclists less likely to suffer serious injury or death than those travelling by car.
"This research dispels the idea that risk for UK cyclists is substantially higher than for drivers or pedestrians, and hopefully will encourage more people to take up something which is not only good for health, but also the environment," said Dr Mindell.
"An individual who cycles one hour a day for 40 years would cover about 180,000km, whilst accumulating only a one in 150 chance of fatal injury. This is lower than for pedestrians who face a higher fatality rate per kilometre travelled," she added. "The health benefits of cycling are much greater than the fatality risk."
Active travel - defined as walking or cycling - is estimated to save £17bn in healthcare costs alone, according to a recent Lancet paper.
University College London: http://www.ucl.ac.uk
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Doctors have used perfect replicas of childrens' hearts to uncover and repair hidden defects
An experiment testing people’s altruism in the face of electric shocks is clear on one thing: we are drawn to these little blasts
Researchers gear up tests in West Africa to see whether blood from Ebola survivors can help people who are sick with the disease. This is part of a broader effort to test therapies in West Africa.
The virus's foray into Europe coincides with peak production of Christmas turkeys, the poultry species most vulnerable to bird flu
A novel kind of nanoparticle could lead to more effective cancer treatments.Patients and doctors often don’t know if surgery to remove cancerous tissue was successful until scans are performed months later. A new kind of nanoparticle could show patients if they’re in the clear much earlier.
One challenge in evaluating the effectiveness of different medical procedures, is that patients behave differently after different procedures. Is this true for patients getting heart surgery?
It is only in the aftermath of treatment that survivors discern that their adrenalin alone wont fuel the rest of their recovery. For many, surviving cancer is followed by even more hardship
Just down the road from Facebook and Google, Dr. Phil Wagner runs a laboratory dedicated to optimizing the performance of some of the world's top athletes. At Sparta Performance Science in Menlo Park, California, Wagner and his team bring the spirit of Silicon Valley to bear on the athletic world, helping athletes find the tiny advantages that add to championships. Join us for a trip inside the lab to see where sports meets science.
Pieter Cohen, an internist in Massachusetts, got interested in dietary supplements several years ago, when some of his …
The risk of overdiagnosis and false positives means the UK may be barking up the wrong tree in trialling a wider target age range for breast screening